Medications for Gaucher Disease Type 1

4 results
  • cerdelga - eliglustat capsule

    (Eliglustat)
    Genzyme Corporation
    Cerdelga is indicated for long-term treatment of adults with Gaucher disease type 1 (GD1) who are CYP2D6 extensive, intermediate, or poor metabolizers as detected by an FDA-cleared test.
  • cerezyme - imiglucerase injection, powder, lyophilized, for solution

    (Imiglucerase)
    Genzyme Corporation
    Cerezyme treats non-central nervous system manifestations of Type 1 and Type 3 Gaucher disease in adults and pediatric patients.
  • elelyso - taliglucerase alfa injection, powder, lyophilized, for solution

    (Taliglucerase Alfa)
    Pfizer Laboratories Div Pfizer Inc
    ELELYSO treats Type 1 Gaucher disease in patients aged 4 years and older with a confirmed diagnosis.
  • zavesca - miglustat capsule

    (Miglustat)
    Actelion Pharmaceuticals Us, Inc.
    ZAVESCA is indicated as monotherapy for adults with mild to moderate type 1 Gaucher disease when enzyme replacement therapy is not an option due to allergy, hypersensitivity, or poor venous access.